Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Y-mAbs Therapeutics Inc have a median target of 21.50, with a high estimate of 26.00 and a low estimate of 11.00. The median estimate represents a 53.57% increase from the last price of 14.00.
High | 85.7% | 26.00 |
Med | 53.6% | 21.50 |
Low | -21.4% | 11.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -157.42% |
Average growth rate | +8.58% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.12% |
Average growth rate | +61.72% |
More ▼